These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27890424)

  • 1. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Sankanagoudar S; Sharma H; Choudhary GR; Pareek P; Vishnoi JR; Sharma P
    Urol Oncol; 2020 Dec; 38(12):918-928. PubMed ID: 32622720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.
    Lichner Z; Ding Q; Samaan S; Saleh C; Nasser A; Al-Haddad S; Samuel JN; Fleshner NE; Stephan C; Jung K; Yousef GM
    J Pathol; 2015 Oct; 237(2):226-37. PubMed ID: 26011734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N; Baruah MM
    Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis.
    Leite KR; Tomiyama A; Reis ST; Sousa-Canavez JM; Sañudo A; Camara-Lopes LH; Srougi M
    Urol Oncol; 2013 Aug; 31(6):796-801. PubMed ID: 21880514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
    Ebron JS; Shukla GC
    Prostate; 2016 Jun; 76(9):834-44. PubMed ID: 26988939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
    Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
    Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor and miR-206 regulation in prostate cancer.
    Chua FY; Adams BD
    Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
    Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
    Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs Role in Prostate Cancer.
    Balacescu O; Dumitrescu RG; Marian C
    Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
    Bertoli G; Cava C; Castiglioni I
    Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics regulation of prostate cancer: Biomarker and therapeutic potential.
    Ragavi R; Muthukumaran P; Nandagopal S; Ahirwar DK; Tomo S; Misra S; Guerriero G; Shukla KK
    Urol Oncol; 2023 Aug; 41(8):340-353. PubMed ID: 37032230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.
    Farran B; Dyson G; Craig D; Dombkowski A; Beebe-Dimmer JL; Powell IJ; Podgorski I; Heilbrun L; Bolton S; Bock CH
    Carcinogenesis; 2018 Apr; 39(4):556-561. PubMed ID: 29471417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.